5.35
-0.30
(-5.31%)
At close: January 10 at 9:35:50 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
64,002.00
64,214.00
79,586.00
151,198.00
Total Liabilities Net Minority Interest
49,176.00
37,453.00
37,218.00
48,647.00
Total Equity Gross Minority Interest
14,826.00
26,761.00
42,368.00
102,551.00
Total Capitalization
14,826.00
26,761.00
42,368.00
103,979.00
Common Stock Equity
14,826.00
26,761.00
42,368.00
102,551.00
Capital Lease Obligations
5,400.00
7,627.00
9,378.00
6,973.00
Net Tangible Assets
14,826.00
26,761.00
40,984.00
68,585.00
Working Capital
42,315.00
45,320.00
39,669.00
55,783.00
Invested Capital
14,826.00
26,761.00
42,368.00
104,309.00
Tangible Book Value
14,826.00
26,761.00
40,984.00
68,585.00
Total Debt
5,400.00
7,627.00
9,378.00
8,731.00
Share Issued
26,523.88
17,719.72
5,888.22
3,845.27
Ordinary Shares Number
26,523.88
17,719.72
5,888.22
3,845.27
Preferred Shares Number
29,383.62
29,383.62
29,383.62
29,383.62
12/31/2020 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
41X.SG Ardelyx Inc
4.8570
-5.03%
BRNS Barinthus Biotherapeutics plc
1.0300
-9.65%
QLGN Qualigen Therapeutics, Inc.
4.2800
+2.64%
TENX Tenax Therapeutics, Inc.
6.24
-2.88%
AUTL Autolus Therapeutics plc
2.3600
-2.07%
APVO Aptevo Therapeutics Inc.
4.7900
-3.82%
PALI Palisade Bio, Inc.
1.9100
-4.98%
FBIO Fortress Biotech, Inc.
2.0300
-2.40%
TPST Tempest Therapeutics, Inc.
0.9494
-3.67%
LXRX Lexicon Pharmaceuticals, Inc.
0.7662
-10.86%